News resources

Today's most mentioned stocks
LM Ericsson Telephone ADR Reptg 1 Ord Shs Class B (ERIC)4 stories...
Incyte Corp (INCY)3 stories...
Goldman Sachs Group Inc (GS)3 stories...
Nortel Networks Corp (NRTLQ)2 stories...
Microsoft Corp (MSFT)2 stories...
Topics in the news
Earnings Reports
Movers
Market Reports
Economic Indicators
Mergers and Acquisitions
advertisement

Pfizer Inc: All Recent News

Final Glance: Pharmaceuticals companies 11/24/2009
NEW YORK (AP) - Shares of some top pharmaceuticals companies were mixed at the close of trading:... Associated Press
4 Platform Drugmakers to Invest In 11/24/2009
No special shoes required. At Motley Fool
Big Winners for Small Investors 11/24/2009
The secret to 50%-per-year returns is revealed. At Motley Fool
Early Glance: Pharmaceuticals companies 11/24/2009
NEW YORK (AP) - Shares of some top pharmaceuticals companies are mixed at 10 a.m.:... Associated Press
A Rorschach on Health Care? Pfizer Hit With $28M in Punitives 11/24/2009
... At Wall Street Journal
Zeroing In On What's Important 11/23/2009
Pfizer's Amy Schulman on how she makes the most of every minute. At Forbes
Pfizer told to pay $28 mln damages in Prempro case 11/23/2009
... At Thomson Reuters
Sage Advice On Vytorin 11/23/2009
So what is the bottom line on the continuing kerfluffle over the cholesterol drugs Zetia and Vytorin, sold by Merck? The basic problem is this: What should patients and doctors do when insufficient data is collected on a new medicine? Merck has lots of studies showing that Zetia lowers cholesterol, but there are no studies that ... At Forbes
Speculating On $1,500 Gold 11/23/2009
If you think the price of gold can go 30% higher by next June, then this is a trade you'll like. At Forbes
The Side Effect of Developing Obesity Drugs 11/23/2009
The FDA is fickle when it comes to weight-loss drugs. At Motley Fool
Healthcare Stocks: Safe and Speculative 11/23/2009
NEW YORK (TheStreet) -- Allos Therapeutics is the best speculative bet in the sector. Watch this video for the safest and biggest growth stock to add to your portfolio. At TheStreet.com
Does Pfizer CEO Regret Sale of Consumer Products to J&J? 11/23/2009
... At Wall Street Journal
Pfizer, Immunovaccine in animal vaccine deal 11/23/2009
NEW YORK (AP) - Immunovaccine Inc. said Monday that Pfizer Inc., the world's largest drugmaker, is licensing its technology for use in vaccines for cattle. Associated Press
Jeff Saut: Was the Long Position a Bad Trade? 11/23/2009
Editor's Note: The following article was written by Raymond James Chief Investment Strategist Jeff Saut. It has been reproduced with permission for the benefit of the Minyanville community. I asked the obligatory question: “How do you decide when to make a trade?” “Through experience ” he says propping his foot up on a small fold-out seat screwed to his post. “Over the course of 18 years as a specialist I’ve had every type of experience -- up market and down market people getting shot wars you name it -- and you learn how to react based on those... At Minyanville
($) Sanofi Has Lots of Upside Catalysts 11/23/2009
Looks like the patent worries aren't so dire after all. At TheStreet.com
More recent US:PFE headlines...
More News
Market Report
News by Symbol
Today's Investing Articles
Breaking News
News by Topic
News by Industry
MSNBC News
MSN Money
Search MSN Money
Message Boards
Site Status